Beyond the Surface: Evolving Standards in Acne Management June marks Acne Awareness Month, serving as a critical pivot point to reframe acne vulgaris not as a temporary phase, but as…
Read More
Metformin and Skin Cancer: Emerging Evidence for Dermatologic Oncology If you are curious about metabolic agents in dermatologic oncology this JDD article is a must read. A new review synthesizes…
Read More
New JDD study examines a combined regimen for PIH in skin of color Have you had a chance to review the latest JDD data on treating PIH? A recent single…
Read More
Over 70 Submissions Focused on Dermatology for Skin of Color In April, as the official media partner of Skin of Color Update (SOCU), JDD published the SOCU 2025 Abstract Poster…
Read More
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color Have you read one of the latest articles published in JDD titled, “Delays…
Read More
From the Vault: In this article from JDD, a multi state BRFSS analysis finds higher skin cancer history in rural populations and In this article from the JDD vault, authors…
Read More
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Read More
From the Vault: Vitiligo trials lag on diversity - US studies underrepresent non‑White and Hispanic patients We are pulling this article from the JDD vault. It’s a July 2024 article…
Read More
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Read More
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Read More
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Read More
A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH. Worth a look for patients with FST V–VI Facial rejuvenation that's both effective and safe in…
Read More
